Production of Soluble Human Vascular Endothelial Growth Factor VEGF-A165-Heparin Binding Domain in Escherichia coli
Author(s) -
Arefeh Seyedarabi,
Lili Cheng,
Ian Zachary,
Snežana Djordjević
Publication year - 2013
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0055690
Subject(s) - vascular endothelial growth factor , angiogenesis , neuropilin 1 , vasculogenesis , heparin , vascular endothelial growth factor a , vegf receptors , chemistry , recombinant dna , microbiology and biotechnology , biochemistry , biology , cancer research , endothelial stem cell , in vitro , gene
We report a method for production of soluble heparin binding domain (HBD) of human vascular endothelial growth factor VEGF-A 165 . Recombinant VEGF-A 165 -HBD that contains four disulphide bridges was expressed in specialised E. coli SHuffle cells and its activity has been confirmed through interactions with neuropilin and heparin. The ability to produce significant quantities of a soluble active form of VEGF-A 165 -HBD will enable further studies addressing the role of VEGF-A in essential processes such as angiogenesis, vasculogenesis and vascular permeability.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom